First Experience in the Field of Bone Marrow Transplantation at the St.-Peterburg BMT Center
A significant proportion of patients, who did develop acute leukemia (AL), chronic myelogenous leukemia (CML), non-Hodgkin’s (NHL), Hodgkin’s disease (HD), multiple myeloma (MM), severe aplastic anemia (SAA), myelodysplastic syndrom (MDS) and other malignancies may be cured with allogeneic (alio), autologous (auto) bone marrow and/or peripheral blood stem cell transplantation (PBSCT). This article deals with first results of BMT and PBSCT performed at Petrov Research Institute of Oncology.
KeywordsToxicity Lymphoma Leukemia Anemia Melphalan
Unable to display preview. Download preview PDF.